Short Interest in Healios K.K. (OTCMKTS:HLOSF) Expands By 31.1%

Healios K.K. (OTCMKTS:HLOSF) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 142,200 shares, anincreaseof31.1% from the July 15th total of 108,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Healios K.K. Stock Performance

Shares of OTCMKTS:HLOSF opened at $4.11 on Friday. The business has a 50 day moving average price of $3.48 and a 200 day moving average price of $2.54. Healios K.K. has a twelve month low of $0.96 and a twelve month high of $4.45.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.